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• Systematic reviews and meta-analysis
• Meta-analysis in Stata
• Bias in meta-analysis
• Stata commands to investigate bias
• Present situation
•T h e  F u t u r e … …Systematic reviews
• Systematic approach to minimize biases and random 
errors
• Always includes materials and methods section
• May include meta-analysis
Chalmers and Altman 1994Meta-analysis
• A statistical analysis which combines the results of 
several independent studies considered by the analyst to 
be ‘combinable’
Huque 1988Streptokinase (thrombolytic therapy)
• Simple idea if we can dissolve the blood clot causing 
acute myocardial infarction then we can save lives
• However – possible serious side effects















































8595 791 1988 ISIS-2 22
5852 628 1986 GISSI-1 21
882 54 1986 ISAM 20
159 25 1977 3rd European 19
118 25 1977 2nd Australian 18
26 5 1977 Witchitz 17
234 63 1977 N German 16
11 1 1977 Lasierra 15
376 37 1977 Austrian 14
9 4 1976 Klein 13
293 48 1976 UK Collaborative 12
53 6 1975 Frank 11
42 11 1975 Valere 10
54 7 1974 NHLBI SMIT 9
253 26 1973 1st Australian 8
104 13 1973 2nd Frankfurt 7
357 69 1971 2nd European 6
157 19 1971 Italian 5
207 22 1971 Heikinheimo 4
84 20 1969 1st European 3
21 4 1963 Dewar 2
11 1 1959 Fletcher 1
Total Deaths
Pub 






1.35 (0.74,2.45) 1st European
1.22 (0.67,2.24) Heikinheimo
1.01 (0.55,1.85) Italian
0.70 (0.53,0.92) 2nd European
0.46 (0.25,0.83) 2nd Frankfurt
0.78 (0.48,1.27) 1st Australian
2.38 (0.65,8.71) NHLBI SMIT
1.05 (0.48,2.28) Valere
0.96 (0.33,2.80) Frank




1.16 (0.84,1.60) N German
0.81 (0.26,2.51) Witchitz
0.85 (0.54,1.34) 2nd Australian





0.1 11 0Archie Cochrane (1979)
“ It is surely a great criticism of our profession that we have not 
organized a critical summary, by specialty or subspecialty, adapted 
periodically, of all relevant randomized controlled trials ”The Cochrane Collaboration
• “An international organization that aims to help people make well 
informed decisions about health care by preparing, maintaining and 
ensuring the accessibility of systematic reviews of the effects of 
health care interventions”
– Ten principles: collaboration, building on the enthusiasm of individuals, 
avoiding duplication, minimizing bias, keeping up to date, striving for 
relevance, promoting access, ensuring
quality, continuity, enabling wide participation
• To date, more than 3000 reviews or protocols
for reviews have been published, and a 
database of more than 375,000 trials has 
been accumulated
• See www.cochrane.orgFixed (common) effect meta-analysis






i i OR   log
• This assumes that the effect of diuretics is the same 
(Fixed) in each study
• Individuals are only compared with others in the same 
study
• It seems sensible to give more weight to the bigger studies• The choice of weight that minimises the variability of the 
summary log OR is wi = 1/vi, where is vi is the variance 
(variance=s.e.2) of the log odds ratio in study i
• The variance of the pooled log OR is 
• This can be used to calculate confidence intervals, a z
statistic and hence a P value for the pooled log odds ratio 
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0.80 (0.75,0.85) Overall (95% CI)
Risk ratio
0.1 11 0Forest plots
• Boxes draw attention to the studies with the greatest 
weight
• Box area is proportional to the weight for the 
individual study
• The diamond (and broken vertical line) represents the 
overall summary estimate, with confidence interval 
given by its width
• Unbroken vertical line is at the null value (1)Random-effects meta-analysis (1)
• We suppose the true treatment effect in each study is 
randomly, normally distributed between studies, with 
variance τ2 (“tau-squared”)
• Estimate the between-study variance τ2, and use this to 
modify the weights used to calculate the summary 
estimate.
• The usual estimate of τ2 is called the DerSimonian and 
Laird estimate.Random-effects meta-analysis (2)



























=1 iΣBack to 1996….
• Bill Clinton always in the news….
• In the UK, Labour look unbeatable….
• England’s stars crash out of the European football 
championship….
• JS gets his first laptopStata 5 (1996)
• A revolutionary advance, based on the Windows 
environment!
• Host of new facilities, including……
• A new graphics programming command (gph)The meta command
(Sharp and Sterne)
• Inverse-variance weighted fixed- and random-effects 
meta-analysis
• Forest plots, programmed using the gph command
• Published in the Stata Technical Bulletin, in 1997
• Syntax: meta logor selogor, options…
Meta-analysis (exponential form)
| Pooled  95% CI      Asymptotic      No. of
Method|    Est  Lower  Upper z_value  p_value  studies
Fixed |  0.774  0.725  0.826  -7.711   0.000    22
Random|  0.782  0.693  0.884  -3.942   0.000
Test for heterogeneity: Q= 31.498 on 21 df (p= 0.066)
Moment-based estimate of variance =  0.017Odds ratio
























meta logor selogor, graph(f) id(trialnam)





Oxford Textbook of 
Medicine 1987
“the clinical value of 
thrombolysis … remains 
uncertain”The metacum command (Sterne 1998)
metacum logor selogor, effect(f) graph 
id(trialnam) eform xlab(0.01,0.1,1,10) 
cline xline(1) b2title(Odds ratio)
Odds ratio























• Mike Bradburn, Jon Deeks and Douglas Altman actually 
knew something about meta-analysis… 
• The Cochrane Collaboration was about to release a new 
version of its Review manager software, and some 
checking algorithms were needed
• Mike Bradburn presented a version of his meta command 
at the 1997 UK Stata Users’ group
“When I found out you’d published your meta 
command, I sulked for quite a few months, 
before I could face finishing our command”The metan command
(Bradburn, Deeks and Altman 1998)
• Input based on the 2×2 table as well as on summary 
statistics (which are automatically calculated)
• Wide range of measures and methods
– Mantel-Haenszel method and Peto method as well as inverse-
variance weights
– Risk ratio and risk difference as well as odds ratios
• Forest plots included text showing effects and weights
• Generally a more comprehensive command… Odds ratio
.01 .1 1 10 100
Study
Odds ratio
(95% CI) % Weight
Fletcher 0.16 ( 0.01, 1.73) 0.2 
Dewar 0.47 ( 0.11, 1.94) 0.3 
1st European 1.46 ( 0.69, 3.10) 0.5 
Heikinheimo 1.25 ( 0.64, 2.42) 0.8 
Italian 1.01 ( 0.51, 2.01) 0.8 
2nd European 0.64 ( 0.45, 0.90) 3.8 
2nd Frankfurt 0.38 ( 0.18, 0.78) 1.2 
1st Australian 0.75 ( 0.44, 1.31) 1.4 
NHLBI SMIT 2.59 ( 0.63, 10.60) 0.1 
Valere 1.06 ( 0.39, 2.88) 0.4 
Frank 0.96 ( 0.29, 3.19) 0.3 
UK Collab 0.88 ( 0.57, 1.35) 2.1 
Klein 3.20 ( 0.30, 34.59) 0.0 
Austrian 0.56 ( 0.36, 0.87) 2.7 
Lasierra 0.22 ( 0.02, 2.53) 0.1 
N German 1.22 ( 0.80, 1.85) 1.9 
Witchitz 0.78 ( 0.20, 3.04) 0.2 
2nd Australian 0.81 ( 0.44, 1.48) 1.1 
3rd European 0.42 ( 0.24, 0.72) 2.0 
ISAM 0.87 ( 0.60, 1.27) 2.8 
GISSI-1 0.81 ( 0.72, 0.90) 32.5 
ISIS-2 0.75 ( 0.68, 0.82) 44.8 
Overall 0.77 ( 0.72, 0.83) 100.0 
metan d1 h1 d0 h0, or label(namevar=trialnam) 
xlab(0.01,0.1,1,10,100)This week I went through the mails I've received: there’s 
approximately 200 in the six years I've kept. The users have grown; 
this year I have had 27 people write, some more than once (that’s >1 a 
week). The typical mail either asks whether metan can do something 
or how to use it to analyse data. Early requests tended to be basic 
"where's the xtick option?" but others have required more time. There 
were a few bugs too, and so the feedback has helped make metan far 
better than it was in 1998. People have tended to be appreciative too -
one mail this year thanked me for writing it, nothing else.
Supporting it is difficult at times: as I work for a cancer charity quite a 
lot of their time has gone into this. Maybe I shouldn't feel uneasy about 
that (most requests were from academia), but I do. In my new job I will 
likely not have the opportunity, save in my own time, to continue this.
Given that Stata has gained publicity and users on the back of these 
routines, it would probably be for the better that Stata’s 1998(?) claim 
that "Stata should have a meta-analysis command [...] but does not" 
were carried into practice.Meta-regression
– used to examine associations between study 
characteristics and treatment effects
– e.g. difference in treatment effect estimates comparing studies 
that were and were not double-blind
–B e r k e yet al. Statistics in Medicine 1995;14:395-411,  
Thompson & Sharp, Statistics in Medicine 1999;18:2693-708
– Observational analyses!!




j j i x β OR   log
Allow for a variance component τ2, which accounts for 
unexplained heterogeneity between studiesThe metareg command (Sharp 1998)
• Iterative estimation procedure:
1. estimate τ2
2. use in a weighted regression to estimate the covariate effects
3. new estimate of τ2 and so on
• Still the only readily-available software?
• Recently adapted by Roger Harbord to use new Stata
procedures to improve estimation of τ2
• Replace existing command or release new one?
“I’d be delighted if someone else took responsibility for 
metareg – I still get a couple of requests for support 
every month and I have no interest in this any more…”
metareg logor studychars, wsse(selogor)
Summary statistics for 
each studyMeta-analysis is no panacea...
• Contrasting conclusions from
– meta-analyses of the same issue
– meta-analyses  and single large trials• “Low molecular weight heparins seem to have 
a higher benefit to risk ratio than
unfractionated heparin in preventing
perioperative thrombosis”
Leizorovicz A et al. BMJ 1992• “There is no convincing evidence that in 
general surgery patients LMWHs, compared 
with standard heparin, generate a clinically 
important improvement in the benefit to risk 
ratio”





Nitrates in myocardial infarction
Inpatient geriatric assessment
Magnesium in myocardial infarction
Aspirin for prevention of 
pre-eclampsia
Intervention:




























































s.e. of: Log odds ratio


























































































Choice of axis in funnel plots































exp(Log odds ratio), log scale
Funnel plot with pseudo 95% confidence limits
metafunnel (Sterne & Harbord 2004)
metafunnel logor selogor, eform xlab(0.1 1 10)Selection models for publication bias
– detect publication bias, based on assuming that a study’s 
results (e.g. the P value) affect its probability of publication
– Example: assume publication is certain if the study P<0.05. If 
P>0.05 then publication probability might be a constant (<1) 
or might decrease with decreasing treatment effect
– More complex models have been proposed, but may require 
much larger numbers of studies than available in typical meta-
analyses
– The complexity of the methods, and the large number of 
studies needed, probably explain why selection models have 
not been widely used in practiceTrim and fill
(Duval & Tweedie 1999, 2000)
metatrim (Steichen 2000)Gangliosides in acute stroke
Odds ratio
Original data


















Filled pointsSelection models are unlikely to account 
(fully) for funnel plot asymmetry
• Statistically significant studies are more likely to 
produce multiple publications
• Large studies are more likely to be published 
whatever their results
• Poorer quality studies produce more extreme 
treatment effects, and are also more likely to be 
small
• The true treatment effect may differ according to 
study size:
– Intensity of intervention
– Differences in underlying risk0.1 0.3 1 3 10 0.6
Bias because of poor quality of 
small trials
Odds ratioSmall study effect
- a tendency for smaller trials in a
meta-analysis to show greater treatment
effects than the larger trials
Small study effects need not result from biasStatistical tests for funnel plot 
asymmetry
• Begg & Mazumdar (Biometrics 1994) - Rank correlation 
test for association between treatment effect and its variance 
(standard error) in each study
• Egger et al. (BMJ 1997) - equivalent to a weighted 
regression of treatment effect on its standard error
Simulation analyses: 
(i) low power unless there is severe bias & a large number of trials
(ii) regression more powerful than rank correlation method 
(iii) problems in some circumstances
(J Clin Epidemiol 2000; 53: 1119-1129 )Tests for funnel plot asymmetry for 
the magnesium trials (exc. ISIS-4)
. metabias logor selogor if trial<16
Tests for Publication Bias
Begg's Test
adj Kendall's Score (P-Q) =    -3
Std. Dev. of Score = 20.21 
Number of Studies =    15
z  = -0.15
Pr > |z| = 0.882
z  =  0.10 (continuity corrected)
Pr > |z| = 0.921 (continuity corrected)
Egger's test
Std_Eff|    Coef  Std Err    t    P>|t|  95% Conf Int
slope| -.15122  .167460  -0.90  0.383  -.51300  .21055
bias| -1.1924  .375174  -3.18  0.007  -2.0029 -.38191
Modified test for 
funnel plot asymmetry 
(Harbord): command 
under developmentOther Stata meta-analysis commands
search meta
metap: Meta-analysis of p-values
A. Tobias
metainf: Assessing the influence of a single 
study in meta-analysis
A. Tobias
galbr: Assessing heterogeneity in meta-
analysis: the Galbraith plot
A. Tobias The present
• Stata should have a meta-analysis command, but it does 
not….
Stata reference manual
• Mike Bradburn has recently left the Centre for Statistics 
in Medicine in Oxford
– metan unlikely to be maintained?
• Very little benefit in maintaining metan and meta as 
separate commands

























10 20 30 40
Mileage (mpg)The future
1. Update graphical displays to Stata 8
• new talent is replacing tired old programmers bewildered by 
Stata 8 graphics
2. Unify existing commands into one or more official Stata 
commands


















.01 .1 1 10
meta8 logor selogor, id(trialnam) eform
graph(f) xlab(0.01 0.1 1 10)
Odds ratio




(95% CI) % Weight
1980s
Morton 0.44 ( 0.04, 5.02) 0.1 
Rasmussen 0.35 ( 0.15, 0.78) 1.0 
Smith 0.28 ( 0.06, 1.36) 0.3 
Abraham 0.96 ( 0.06, 15.77) 0.0 
Feldstedt 1.25 ( 0.48, 3.26) 0.3 
Schechter 0.09 ( 0.01, 0.74) 0.4 
Ceremuzynski 0.28 ( 0.03, 2.88) 0.1 
Subtotal 0.44 ( 0.27, 0.71) 2.4 
1990s
Singh 0.50 ( 0.17, 1.43) 0.5 
Pereira 0.11 ( 0.01, 0.97) 0.3 
Schechter 1 0.13 ( 0.03, 0.60) 0.6 
Golf 0.43 ( 0.13, 1.44) 0.4 
Thogersen 0.45 ( 0.13, 1.54) 0.4 
LIMIT-2 0.74 ( 0.56, 0.99) 5.0 
Schechter 2 0.21 ( 0.07, 0.64) 0.8 
ISIS-4 1.06 ( 1.00, 1.13) 89.7 
Subtotal 1.02 ( 0.96, 1.08) 97.6 
Overall 1.01 ( 0.95, 1.07) 100.0 
metan dead1 alive1 dead0 alive0, or by(period) 
label(namevar=trialnam)New developments
• Meta-analysis of diagnostic tests
– Major area of expansion for the Cochrane Collaboration
– Statistically, much more complex than meta-analysis of 
randomised controlled trials
– First command (meta_lr) recently released by Aijing Shang
– Formal synthesis of these studies requires bivariate methods 
accounting for the association between sensitivity and 
specificity (meta-analyse in ROC-space)
– Obvious extensions to existing ROC methods in Stata
– Opportunities to use gllamm and new mixed models 
procedures to be released in Stata 9?
• As always, developments will occur in areas that no-one 
predicts…Thanks to…
• Stephen Sharp
• Matthias Egger
• Tom Steichen
• Mike Bradburn
• Roger Harbord
• Aijing Shang